PBK as a Potential Biomarker and Therapeutic Target for Metastatic Pheochromocytomas and Paragangliomas
PBK serves as a novel metastasis-related biomarker and a promising therapeutic target in PPGLs. Incorporation of the PBK index into risk models may refine metastasis prediction.
Authors
- Zewen Li
- Yue Zhou (ORCID: https://orcid.org/0000-0002-2639-6934)
- Yunying Cui
- Tianyi Li (ORCID: https://orcid.org/0000-0001-7038-7798)
- Wenqian Zhang
- Anli Tong (ORCID: https://orcid.org/0000-0002-1418-1012)
Institutions
- Hebei North University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1210/clinem/dgaf575
- Citations
- 1
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 1.29